IDOVEN new member of the MAESTRIA H2020 consortium | IDOVEN

We at IDOVEN are honored and grateful to announce our incorporation as members of the MAESTRIA H2020 Consortium.

H2020 is the largest research and innovation program in the history of the European Union, with nearly 80 billion euros in funding allocated over seven years.

MAESTRIA is a collaborative project that brings together Europe’s leading centers in atrial fibrillation research, funded by the European Commission under the Horizon 2020 Research and Innovation Program.

The MAESTRIA Consortium (Machine Learning and Artificial Intelligence for Early Detection of Stroke and Atrial Fibrillation) is developing the most extensive and diverse database on atrial fibrillation ever created in medical history.

This digital platform is designed to assist doctors and their patients in achieving greater diagnostic accuracy, enhancing the effectiveness and efficiency of treatments. Additionally, it aims to aid in the prevention of complications associated with atrial cardiomyopathy, such as atrial fibrillation, thrombi, and strokes.

The MAESTRIA project team, alongside IDOVEN and 17 other consortium partners, is working to develop and validate the first integrative digital diagnostic platform for atrial fibrillation. Atrial fibrillation is the most common sustained cardiac arrhythmia in the general population. Recent data indicate that it affects over 4% of people aged 40 and older. Given the magnitude of this public health issue, this alliance among major European research centers seeks to enhance its prevention, diagnosis, and treatment.

The goal of the project is to create multi-parametric digital tools that leverage a new generation of biomarkers, integrating artificial intelligence (AI) and big data processing from state-of-the-art imaging, electrocardiography, and omics technologies.

IDOVEN is proud to be a part of the esteemed MAESTRIA Consortium, which has secured 14 million euros in funding from the European Horizon 2020 program.

This groundbreaking project, set to shape the future of digital atrial fibrillation diagnosis, is coordinated by Sorbonne University in Paris (Principal Investigator: Stéphane Hatem) and involves 17 other European and international partners: University of Oxford (UK), University of Birmingham (UK), Kompetenznetz Vorhofflimmern EV (Germany), Essen University Hospital (Germany), Maastricht University (Netherlands), National and Kapodistrian University of Athens (Greece), Centro Nacional de Investigaciones Cardiovasculares CNIC (Spain), Centre de recherche du CHUS (Canada), Siemens Healthcare GMBH (Germany), Caristo Diagnostics (UK), Owkin (France), Preventicus GMBH (Germany), Yourrhythmics (Netherlands), and IDOVEN (Spain).